These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12799559)

  • 1. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia.
    Stringer EM; Sinkala M; Stringer JS; Mzyece E; Makuka I; Goldenberg RL; Kwape P; Chilufya M; Vermund SH
    AIDS; 2003 Jun; 17(9):1377-82. PubMed ID: 12799559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia.
    Stringer JS; Sinkala M; Maclean CC; Levy J; Kankasa C; Degroot A; Stringer EM; Acosta EP; Goldenberg RL; Vermund SH
    AIDS; 2005 Aug; 19(12):1309-15. PubMed ID: 16052086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study.
    Conkling M; Shutes EL; Karita E; Chomba E; Tichacek A; Sinkala M; Vwalika B; Iwanowski M; Allen SA
    J Int AIDS Soc; 2010 Mar; 13():10. PubMed ID: 20230628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-home HIV testing and nevirapine dosing by traditional birth attendants in rural Zambia: a feasibility study.
    Brennan AT; Thea DM; Semrau K; Goggin C; Scott N; Pilingana P; Botha B; Mazimba A; Hamomba L; Seidenberg P
    J Midwifery Womens Health; 2014; 59(2):198-204. PubMed ID: 24106818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings.
    Stringer JS; Sinkala M; Stout JP; Goldenberg RL; Acosta EP; Chapman V; Kumwenda-Phiri R; Vermund SH
    J Acquir Immune Defic Syndr; 2003 Apr; 32(5):506-13. PubMed ID: 12679702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.
    Sweat MD; O'Reilly KR; Schmid GP; Denison J; de Zoysa I
    AIDS; 2004 Aug; 18(12):1661-71. PubMed ID: 15280777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women in couples antenatal HIV counseling and testing are not more likely to report adverse social events.
    Semrau K; Kuhn L; Vwalika C; Kasonde P; Sinkala M; Kankasa C; Shutes E; Aldrovandi G; Thea DM
    AIDS; 2005 Mar; 19(6):603-9. PubMed ID: 15802979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia.
    Megazzini KM; Sinkala M; Vermund SH; Redden DT; Krebs DW; Acosta EP; Mwanza J; Goldenberg RL; Chintu N; Bulterys M; Stringer JS
    AIDS; 2010 Jan; 24(3):447-55. PubMed ID: 19926959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia.
    Chi BH; Chintu N; Lee A; Stringer EM; Sinkala M; Stringer JS
    J Acquir Immune Defic Syndr; 2007 May; 45(1):125-7. PubMed ID: 17460478
    [No Abstract]   [Full Text] [Related]  

  • 13. Mother-to-child HIV transmission in resource poor settings: how to improve coverage?
    Temmerman M; Quaghebeur A; Mwanyumba F; Mandaliya K
    AIDS; 2003 May; 17(8):1239-42. PubMed ID: 12819526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
    Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
    JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.
    Chi BH; Sinkala M; Mbewe F; Cantrell RA; Kruse G; Chintu N; Aldrovandi GM; Stringer EM; Kankasa C; Safrit JT; Stringer JS
    Lancet; 2007 Nov; 370(9600):1698-705. PubMed ID: 17997151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine.
    Stringer JS; Sinkala M; Chapman V; Acosta EP; Aldrovandi GM; Mudenda V; Stout JP; Goldenberg RL; Kumwenda R; Vermund SH
    AIDS; 2003 Jul; 17(11):1659-65. PubMed ID: 12853748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of rapid HIV testing acceptance and successful nevirapine administration in Zambian labor wards.
    Megazzini KM; Chintu N; Vermund SH; Redden DT; Krebs DW; Simwenda M; Tambatamba B; Sinkala M; Stringer JS
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):273-9. PubMed ID: 19568175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field performance of a thin-layer chromatography assay for detection of nevirapine in umbilical cord blood.
    Chi BH; Lee A; Acosta EP; Westerman LE; Sinkala M; Stringer JS
    HIV Clin Trials; 2006; 7(5):263-9. PubMed ID: 17162321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?
    De Nardo P; Gentilotti E; Nguhuni B; Vairo F; Chaula Z; Nicastri E; Ippolito G
    Expert Rev Anti Infect Ther; 2016; 14(1):19-27. PubMed ID: 26559430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.